Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Stockholders' Equity

v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Common Stock Class A
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at beginning at Dec. 31, 2024 $ 1 $ 1 $ 107,094 $ (87,027) $ 20,069
Balance at beginning (in shares) at Dec. 31, 2024 6,000,000 16,153,610      
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY          
Share-based compensation     1,323   1,323
Exercise of stock options for cash     75   75
Exercise of stock options for cash (In shares)   40,043      
Issuance of common stock for vested restricted stock units (in shares)   50,421      
Issuance of common stock under ESPP     99   99
Issuance of common stock under ESPP (in shares)   25,641      
Issuance of common stock, ATM offering, net of issuance costs     4,048   4,048
Issuance of common stock, ATM offering, net of issuance costs (in shares)   834,722      
Net loss       (4,073) (4,073)
Balance at ending at Mar. 31, 2025 $ 1 $ 1 112,639 (91,100) 21,541
Balance at ending (in shares) at Mar. 31, 2025 6,000,000 17,104,437      
Balance at beginning at Dec. 31, 2025 $ 1 $ 2 130,307 (98,458) 31,852
Balance at beginning (in shares) at Dec. 31, 2025 6,000,000 21,144,655      
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY          
Share-based compensation     989   989
Exercise of stock options for cash     72   72
Exercise of stock options for cash (In shares)   42,150      
Issuance of common stock for vested restricted stock units (in shares)   122,267      
Issuance of common stock under ESPP     148   148
Issuance of common stock under ESPP (in shares)   24,874      
Net loss       (2,230) (2,230)
Balance at ending at Mar. 31, 2026 $ 1 $ 2 $ 131,516 $ (100,688) $ 30,831
Balance at ending (in shares) at Mar. 31, 2026 6,000,000 21,333,946